Clinical Trials on Renal Neoplasms
Total 115169 results
-
AgennixCompletedCarcinoma, Renal CellUnited States
-
National Center for Research Resources (NCRR)Duke UniversityUnknownRenal Cell CarcinomaUnited States
-
Regeneron PharmaceuticalsNot yet recruitingMelanoma | Advanced Solid Tumors | Clear-Cell Renal-Cell Carcinoma (ccRCC)
-
National Cancer Institute (NCI)TerminatedRenal Cell Carcinoma | Renal Cell Cancer | Hereditary LeiomyomatosisUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedKidney Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Metastatic CancerUnited States
-
AmgenCompletedEnd Stage Renal Disease
-
AmgenCompletedEnd Stage Renal Disease
-
AmgenCompletedEnd Stage Renal Disease
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific | Stage III Renal Cell Cancer | Recurrent Endometrial Carcinoma | Stage IV Renal Cell Cancer | Recurrent Renal Cell Cancer | Stage IV Endometrial Carcinoma | Stage III Endometrial Carcinoma | Endometrial Papillary Serous CarcinomaCanada
-
OPKO IP Holdings II, Inc.CompletedChronic Kidney Disease | Secondary Hyperparathyroidism | Chronic Renal Failure | Chronic Renal InsufficiencyCanada, United States
-
Tabriz University of Medical SciencesNot yet recruitingRenal Cell CarcinomaIran, Islamic Republic of
-
Peking Union Medical College HospitalRecruitingDiagnosis of Renal Cell Carcinoma on 68Ga-PSMA PET-CT and Radioligand Therapy With 177Lu-EB-PSMA-617Renal Cell CarcinomaChina
-
Peking University First HospitalNot yet recruiting
-
Universitätsmedizin MannheimDietmar Hopp Stiftung; Institute of Medical Biometry and Informatics, University...Recruiting
-
University College, LondonAstraZeneca; Cancer Research UK; Kidney Cancer UKRecruiting
-
Beth Israel Deaconess Medical CenterRecruitingRenal Cell CarcinomaUnited States
-
Bristol-Myers SquibbCompleted
-
Spanish Oncology Genito-Urinary GroupIpsen; Syntax for Science, S.LCompleted
-
Bristol-Myers SquibbActive, not recruiting
-
PfizerCompletedKidney NeoplasmsUnited States, China, Malaysia, India, Taiwan, Russian Federation, Mexico, Bosnia and Herzegovina, South Africa, Bulgaria, Chile, Philippines, Romania, Ukraine
-
Cancer Trials IrelandNovartisCompletedRenal Cell CarcinomaIreland, Sweden
-
PfizerCompletedRenal Cell CarcinomaUnited States
-
Sohag UniversityCompletedRenal Cell CarcinomaEgypt
-
IpsenCompletedRenal Cell CarcinomaUnited Kingdom
-
UNC Lineberger Comprehensive Cancer CenterCompleted
-
M. LabotsTerminated
-
University of Kansas Medical CenterUnknownRenal Cell CarcinomaUnited States
-
AVEO Pharmaceuticals, Inc.CompletedCarcinoma, Renal CellUkraine, India, Russian Federation
-
Novartis PharmaceuticalsCompletedCarcinoma, Renal CellUnited States, Belgium, Estonia, Italy, Turkey, Austria, Argentina, Germany, Greece, Israel, Spain, United Kingdom, Taiwan, Hungary, Pakistan, Colombia, Finland, Lebanon
-
iOMEDICO AGArbeitskreis Klinische Studien; Bund der Urologen e.G.Completed
-
CelgeneTerminatedRenal Cell CarcinomaUnited States
-
IpsenCompleted
-
Meshalkin Research Institute of Pathology of CirculationCompleted
-
Eisai Co., Ltd.Completed
-
University of PennsylvaniaCompletedRenal Cell CarcinomaUnited States
-
AEterna ZentarisDana-Farber Cancer InstituteCompletedRenal Cell CarcinomaUnited States
-
Mario Negri Institute for Pharmacological ResearchTerminated
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Unknown
-
Centre Francois BaclesseUniversity Hospital, CaenTerminatedRelation Between Safety Endpoints and Everolimus Trough Blood Level in Advanced Renal Cell CarcinomaRenal Cell CarcinomaFrance
-
University of Kansas Medical CenterCelgeneTerminatedRenal Cell CarcinomaUnited States
-
Beth Israel Deaconess Medical CenterGenzyme, a Sanofi CompanyCompleted
-
Beth Israel Deaconess Medical CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)TerminatedRenal Cell CarcinomaUnited States
-
Hoffmann-La RocheCompleted
-
University of PittsburghNational Institutes of Health (NIH)TerminatedRenal Cell CarcinomaUnited States
-
RenJi HospitalUnknown
-
Genentech, Inc.CompletedRenal Cell CarcinomaGermany, Spain, United States, France, United Kingdom
-
GlaxoSmithKlineCompletedCarcinoma, Renal CellItaly, Argentina, Korea, Republic of, Estonia, Hong Kong, Ukraine, Ireland, Latvia, Pakistan, China, Austria, Greece, New Zealand, Poland, Russian Federation, United Kingdom, Australia, India, Czech Republic, Mexico, Brazil, Chile, ... and more
-
BayerCompletedCarcinoma, Renal CellItaly, France, Germany, United Kingdom, Poland
-
Newcastle-upon-Tyne Hospitals NHS TrustCancer Research UKCompleted